BridgeMD
Compares treatment options for Endoscopic Retrograde Cholangiopancreatography
Official title HFNC Versus Microstream Advance Nasal Cannula for Oxygenation During ERCP
ClinicalTrials.gov ID: NCT07611903
What this study is testing
- What it's testing
- Endoscopic retrograde cholangiopancreatography (ERCP) procedures are commonly performed under deep sedation and are associated with a risk of hypoxemia, particularly in prone or semi-prone positions. High-flow nasal cannula (HFNC) therapy may improve oxygenation by delivering heated and humidified oxygen at high flow rates, while the Microstream Advance nasal cannula provides simultaneous nasal oxygen delivery and oral oxygen insufflation.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 84
You may be able to join if
- Patients aged 18 to 84 years
- ASA physical status I-III
- Patients scheduled to undergo ERCP
- Patients who provide written informed consent
You likely can't join if
- Recent history of upper respiratory tract infection
- History of lung cancer
- Chronic obstructive pulmonary disease
- Asthma
- Body mass index greater than 35 kg/m²
- Refusal to participate in the study
The study team makes the final eligibility decision.
Where it's taking place
- Kocaeli, Umuttepe, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 84 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kocaeli, Umuttepe, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.